Elevance Health (NYSE:ELV – Get Free Report) and Clover Health Investments (NASDAQ:CLOV – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.
Earnings and Valuation
This table compares Elevance Health and Clover Health Investments”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Elevance Health | $201.83 billion | 0.42 | $5.66 billion | $23.45 | 16.82 |
| Clover Health Investments | $1.92 billion | 1.03 | -$85.55 million | $0.01 | 371.50 |
Elevance Health has higher revenue and earnings than Clover Health Investments. Elevance Health is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Elevance Health and Clover Health Investments’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Elevance Health | 2.55% | 14.97% | 5.31% |
| Clover Health Investments | 0.45% | 4.66% | 2.43% |
Analyst Ratings
This is a summary of recent ratings and recommmendations for Elevance Health and Clover Health Investments, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Elevance Health | 0 | 7 | 16 | 0 | 2.70 |
| Clover Health Investments | 1 | 3 | 3 | 0 | 2.29 |
Elevance Health currently has a consensus target price of $458.91, suggesting a potential upside of 16.36%. Clover Health Investments has a consensus target price of $5.10, suggesting a potential upside of 37.28%. Given Clover Health Investments’ higher probable upside, analysts clearly believe Clover Health Investments is more favorable than Elevance Health.
Insider and Institutional Ownership
89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Volatility and Risk
Elevance Health has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500. Comparatively, Clover Health Investments has a beta of 2.52, indicating that its stock price is 152% more volatile than the S&P 500.
Summary
Elevance Health beats Clover Health Investments on 9 of the 14 factors compared between the two stocks.
About Elevance Health
Elevance Health, Inc. is a U.S. health benefits and services company. Formerly known as Anthem, Inc., it adopted the Elevance Health name in 2022 while retaining the Anthem brand for many of its health plans. The company offers medical, pharmacy, dental, vision and behavioral health coverage, including plans for individuals and employers as well as programs serving Medicare and Medicaid members. Its services also include care management, pharmacy benefit services and other health-related capabilities through its Carelon business.
About Clover Health Investments
Clover Health Investments is a U.S. healthcare company focused on Medicare. Its insurance business offers Medicare Advantage plans to eligible beneficiaries in select markets, combining medical coverage with support intended to help members access care. The company also developed the Clover Assistant, a technology platform that organizes patient information and provides clinicians with insights to support care decisions. Clover has described the platform as a way to help primary care providers identify health needs and coordinate care for people with complex conditions.
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.
